Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinoma
- PMID: 2870577
- DOI: 10.1007/BF02889905
Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinoma
Abstract
The histology of immunologically mediated tumor regression was studied in the syngenic strain 2 guinea pig/line 10 hepatocellular carcinoma tumor system. Tumor regression was induced non-specifically by the intralesional injection of living Bacillus Calmette-Guérin (BCG) in 7-day-old established tumors (diameter 8-10 mm). In untreated line 10 tumors at day 7 a mild to moderate inflammatory reaction was present, which consisted mainly of small mononuclear cells; in addition large mononuclear cells and basophils were present. Intratumoral BCG-treatment induced a prominent increase in the inflammatory reaction due to an influx of small and large mononuclear cells and neutrophils. Small mononuclear cells were identified mainly as lymphocytes whereas large mononuclear cells belonged mainly to the macrophage line. Intratumoral administration of BCG resulted in a granulomatous reaction. A time-related decrease in the number of tumor cells and an increase in inflammation, associated with purulent lysis of the granulomatous tissue, was observed. Specific immune-mediated tumor rejection occurred in animals both after active immunization and after adoptive transfer of immune spleen cells. In actively immunized animals the tumor cells were rapidly rejected and from day 4 onwards no tumor cells could be detected at the injection site. Lymphocytes were the major component of the inflammatory reaction; large mononuclear cells were present to a lesser extent and basophilic granulocytes were regularly observed. After adoptive transfer of immunity with immune spleen cells given simultaneously with an intradermal innoculation of tumor cells, an essentially similar rejection reaction was found, although tumor cell rejection was delayed. Lymphocytes and large mononuclear cells were found in equal proportions, whereas basophilic granulocytes were always present in smaller numbers. After BCG-induced regression and in adoptively transferred immune rejection, a fibroblast component was more prominent than in untreated control tumors. This reaction tended to isolate smaller tumor cell areas into islets of decreasing sizes. In contrast with the fibroblast component of growing tumors, the proliferative pre-existing fibrous tissue in tumors undergoing regression or rejection showed a loosely arranged architecture and contained a marked cellular infiltrate. From the results of the present study it was concluded that the morphological expression of line 10 tumor rejection varies. Without immune cells, BCG is needed for the induction of a local inflammatory reaction, which was granulomatous in type and eventually led to complete tumor cell eradication.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.J Immunol. 1985 Mar;134(3):2032-40. J Immunol. 1985. PMID: 2578526
-
Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.J Natl Cancer Inst. 1977 Mar;58(3):803-8. doi: 10.1093/jnci/58.3.803. J Natl Cancer Inst. 1977. PMID: 320348
-
A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.Cancer Res. 1976 Dec;36(12):4459-66. Cancer Res. 1976. PMID: 187324
-
Mechanism of BCG induced regression of line 10 hepatocarcinoma in the guinea pig.In Vivo. 1991 Nov-Dec;5(6):655-61. In Vivo. 1991. PMID: 1810452 Review.
-
Cellular mechanisms of tumor rejection in rats.Nat Immun Cell Growth Regul. 1990;9(1):1-25. Nat Immun Cell Growth Regul. 1990. PMID: 2184350 Review.
Cited by
-
Coley's Toxin to First Approved Therapeutic Vaccine-A Brief Historical Account in the Progression of Immunobiology-Based Cancer Treatment.Biomedicines. 2024 Nov 30;12(12):2746. doi: 10.3390/biomedicines12122746. Biomedicines. 2024. PMID: 39767654 Free PMC article. Review.
-
Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guérin.Cancer Immunol Immunother. 1990;31(3):182-6. doi: 10.1007/BF01744734. Cancer Immunol Immunother. 1990. PMID: 2337907 Free PMC article.
-
Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression.Cancer Immunol Immunother. 1991;33(3):189-97. doi: 10.1007/BF01756141. Cancer Immunol Immunother. 1991. PMID: 1828389 Free PMC article.